THERAMAX COLD & FLU RELIEF NASAL SPRAY

Manufacturer
THERABIOGEN | COSMEDX SCIENCE, INC
Effective date
2010-10-06
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 02:02:39

Label at a glance#

ProductTHERABIOGEN COLD AND FLU RELIEF NASAL
Active ingredientGREEN TEA LEAF, SAMBUCUS NIGRA FLOWERING TOP, GELSEMIUM SEMPERVIRENS ROOT, BRYONIA ALBA ROOT, SULFUR
Label structure15 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Drug Facts

Active Ingredients                                                            Purpose

Camellia Sinensis    3X                                                           Cold and Flu Symptom Relief

Sabmucus Nigra 2X                                                                  Cold and Flu Symptom Relief

Gelsemium sempervirens 6X, 12X 30X                                 Cold and Flu Symptom Relief

Bryonia alba 6X                                                                     Cold and Flu Symptom Relief

Sulphur 12X                                                                           Cold and Flu Symptom Relief

OTC - PURPOSE SECTION

Purpose

Cold and flu symptom relief

INDICATIONS & USAGE SECTION

Uses

Relieves old and flu symptoms

Provides relief from upper respiratory symptoms such as nasal and sinus congestion, runny nose, sore throat, sneezing and headache

Also relieves fever, chills and body aches associated with the flu

WARNINGS SECTION

Warnings

For nasal use only

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

ear, nose or throat sensitivity

susceptible to nose bleeds

OTC - WHEN USING SECTION

When using this product

Avoid contact with eyes. In case of accidental contact with eyes, flush with water and immediately seek professional help.

The use of this container by more than one person may spread infection.

OTC - STOP USE SECTION

Stop use and ask a doctor if symptoms persist

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant of breast feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions

For best results, use at the first sign of cold or flu symptoms and continue to use for an additional 48 hours after symptoms subside

Adults and children 6 years of age and older (with adult supervision):

Remove cap and safety clip also see illustration on side carton and insert).

Hold with thumb at bottom of bottle and nozzle between your fingers

Before using the first tie, prime pump by depressing several times.

Place tip of nozzle just past nazal opening (approxiately 1/8").

While inside nasal opening, slightly angle nozzle outward.

Pump one to tw times into each nostril

After application, press lightly on outside of each nostril for about 5 seconds.

Wait at least 30 seconds before blowing nose

Use once every 4 hours

Children under 6 years of age: consult a doctor before use.

INACTIVE INGREDIENT SECTION

Inactive Ingredients

Benzalkonium chloride, glyerin, hydroxyethylcellulose, potassium phosphate monobasic, sodium chloride, sodium phosphate dibasic, water

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Theramax

Take at the first sign of cold or flu symptoms

No known drug interactions

Non-drowsy

No jitters

Non-habit forming

Homeopathic

Satisfaction guaranteed

Store at room temperature 15C-29C (59F-84F)

Product is naturally dark in color

Questions? Comments?
call 866-284-9561 or visit us on the web at
www.theramaxrelief. com

Developed and distributed by
Therabiogen, Inc. (OTC: TRAB.OB)
New York, NY 10005
(c) 2008 PRODUCT OF USA

HOMEOPATHIC

Theramax

Cold and flu relief

ZINC FREE

Nasal Spray

Relief of:

Nasal and Sinus Congestion

Runny Nose

Sore Throat

Sneezing

Chills and Fever

0.50 fl oz (15 ml) Homeopathic


TheraMax

DIRECTIONS

1.  Remove cap and safety clip

2. Hold with thumb at bottom and nozzle between your fingers

3. Prior to initial use, prime pump by holding it upright and depressing several ties (into a tissue) until the liquid is dispensed

4. Place tip of nozzle just past nasal opening (approximately 1/8")

5. While inside nasal opening, slightly angle nozzle outward, as shown

6. Pump one to two times into each nostril

7. After application, press lightly on the outside of each  nostril for about 5 seconds.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Active Ingredients:

Camellia simensis 3X,

Sambucus nigra 2X

Gelsemium sempervirens 6X, 12X, 30X

Bryonica Alba 6X

Sulphur 12X


Note: Prior to using TheraMax Cold and Flu Relief, read the entire package

(c) 2008 Developed and distributed by Therabiogen, Inc. (OTC: TRABE.OB)

New York, NY 10005

www.theramaxrelief.com

PRODUCT OF USA


TheraMax

Cold and Flu Relief

Zinc Free

Nasal Spary

0.50 fl oz (15 ml)   Homeopathic


Do not use if tamper resistant seal is broken or missing.


Uses: Relieves cold and flu symptoms. Provides relief from upper respiratory symptoms such as nasal and sinus congestion, runny nose, sore throat, sneezing and headach. Also relieves fever, chills, ad body aches associated with the flu.

Questions or commeents:

Call 866-284-9561

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Theramax cold and flu reliefTheramax cold and flu relief

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Theramax cold and flu relief2Theramax cold and flu relief2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4b7700e3-6e0e-45e5-9d22-6f754d61386eProduct name220250304
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
51445-101-152019-10-29C16284748780-1960f7f55-dabd-8e05-e053-dbdaa90a074aTHERAMAX COLD & FLU RELIEF NASAL SPRAY

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51445-101-15THERABIOGEN COLD AND FLU RELIEF NASAL1 in 1 BOXSPRAY13
51445-101-15THERABIOGEN COLD AND FLU RELIEF NASAL15 mL in 1 BOTTLE, SPRAYSPRAY153

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51445-101THERABIOGEN COLD AND FLU RELIEF NASAL (CAMELIA SINENSIS, SAMBUCUS NIGRA, GELSEMIUM SEMPERVIRENS, BRYONIA ALBA, SULPHUR) SPRAY [THERABIOGEN]3Legacy NDC, 2 package rows20101007_17704cc5-96f1-4d10-b5f6-252c6491db49.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BRYONIA ALBA ROOTACTIVE INGREDIENTT7J046YI2B3
GELSEMIUM SEMPERVIRENS ROOTACTIVE INGREDIENT639KR60Q1Q3
GREEN TEA LEAFACTIVE INGREDIENTW2ZU1RY8B03
SAMBUCUS NIGRA FLOWERING TOPACTIVE INGREDIENTCT03BSA18U3
SULFURACTIVE INGREDIENT70FD1KFU703
BRYONIA ALBA ROOTACTIVE MOIETYT7J046YI2B3
GELSEMIUM SEMPERVIRENS ROOTACTIVE MOIETY639KR60Q1Q3
GREEN TEA LEAFACTIVE MOIETYW2ZU1RY8B03
SAMBUCUS NIGRA FLOWERING TOPACTIVE MOIETYCT03BSA18U3
SULFURACTIVE MOIETY70FD1KFU703
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W73
GLYCERININACTIVE INGREDIENTPDC6A3C0OX3
POTASSIUM PHOSPHATE, MONOBASICINACTIVE INGREDIENT4J9FJ0HL513
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8X3
SODIUM PHOSPHATE, DIBASICINACTIVE INGREDIENTGR686LBA743
WATERINACTIVE INGREDIENT059QF0KO0R3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51445-10151445-101-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 266 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XPOWDER, FOR SUSPENSION / ORAL98 mgExact identifier — unii candidate
134 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE, EXTENDED RELEASE / ORAL265 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION / TOPICAL210 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SUSPENSION / INTRA-ARTICULAR26 mgExact identifier — unii candidate
134 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION / OPHTHALMIC58 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSUSPENSION / ORAL1126 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / SUBCUTANEOUS1486 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XDROPS / OPHTHALMIC0.08 %w/wExact identifier — unii candidate
134 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXJELLY / VAGINALNAExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSUSPENSION / SUBCUTANEOUS0.8 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPRAY, METERED / NASAL13 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / OPHTHALMIC55 mgExact identifier — unii candidate
134 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SUSPENSION/ DROPS / AURICULAR (OTIC)0.02 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SOLUTION / SUBCUTANEOUS15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION / NASAL40.46 mg/100mlExact identifier — unii candidate
24 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / AURICULAR (OTIC)25 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSUSPENSION / TOPICAL0.32 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INTRA-ARTERIAL278 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASICSODIUM PHOSPHATE, DIBASICGR686LBA74CREAM / TOPICAL0.1 %w/wExact identifier — unii candidate
14 equally ranked IID candidates
POTASSIUM PHOSPHATE, MONOBASICMONOBASIC POTASSIUM PHOSPHATE4J9FJ0HL51SUSPENSION / OPHTHALMIC0.44 %w/wExact identifier — unii candidate
19 equally ranked IID candidates
POTASSIUM PHOSPHATE, MONOBASICMONOBASIC POTASSIUM PHOSPHATE4J9FJ0HL51INJECTION / INTRAVENOUS68 mgExact identifier — unii candidate
19 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INTRABURSAL9 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASICSODIUM PHOSPHATE, DIBASICGR686LBA74FILM, SOLUBLE / ORAL9 mgExact identifier — unii candidate
14 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / DENTAL0.4 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION / AURICULAR (OTIC)0.01 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS0.86 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXELIXIR / ORAL5621 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE / ORAL3822 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS225 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION / AURICULAR (OTIC)0.05 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / PERINEURAL648 mgExact identifier — unii candidate
134 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, COATED / ORAL1 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAVENOUS15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGEL / OPHTHALMIC0.88 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INTRATHECAL9 mgExact identifier — unii candidate
134 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7OINTMENT / TOPICAL0.03 %w/wExact identifier — unii candidate
24 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SUSPENSION / INTRAMUSCULAR26 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / EPIDURAL648 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSUSPENSION/ DROPS / TOPICAL0.23 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / DENTAL15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7INJECTION / INTRAMUSCULAR1 mgExact identifier — unii candidate
24 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASICSODIUM PHOSPHATE, DIBASICGR686LBA74INJECTION / SUBCUTANEOUS14 mgExact identifier — unii candidate
14 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION / EPIDURAL0.9 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INTRATHECAL131 mgExact identifier — unii candidate
134 equally ranked IID candidates
POTASSIUM PHOSPHATE, MONOBASICMONOBASIC POTASSIUM PHOSPHATE4J9FJ0HL51TABLET / ORAL25 mgExact identifier — unii candidate
19 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPRAY / NASAL22.3 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION, EXTENDED RELEASE / ORAL2000 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, SOLUTION / INTRACAUDAL210 mgExact identifier — unii candidate
134 equally ranked IID candidates
POTASSIUM PHOSPHATE, MONOBASICMONOBASIC POTASSIUM PHOSPHATE4J9FJ0HL51SYRUP / ORAL19 mgExact identifier — unii candidate
19 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSYRUP / ORAL16734 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INFILTRATION648 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INTRAVENOUS28773 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL226 mgExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XTABLET, COATED / ORAL54.7 mgExact identifier — unii candidate
134 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION, CONCENTRATE / ORAL200 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, CHEWABLE / ORAL12 mgExact identifier — unii candidate
75 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XINJECTION / INTRALESIONAL0.9 %w/vExact identifier — unii candidate
134 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION / INTRAMUSCULAR90 mgExact identifier — unii candidate
134 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
877fc49a-0836-4eba-85bb-c8d4241823c917704cc5-96f1-4d10-b5f6-252c6491db492010-10-06WarningsExact identifier
spl id: 877fc49a-0836-4eba-85bb-c8d4241823c9
spl set id: 17704cc5-96f1-4d10-b5f6-252c6491db49

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.